Sanofi

Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs
Fierce Pharma
Tue, 01/21/25 - 07:08 pm
Sanofi
drug manufacturing
FDA
Genzyme
Massachusetts
Could OTC Cialis for erectile dysfunction reach the US?
Pharmaphorum
Tue, 01/21/25 - 11:11 am
Sanofi
consumer healthcare
OTC
Opella
Cialis
erectile dysfunction
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Clinical Trials Arena
Thu, 01/16/25 - 11:09 am
Sanofi
KT-474
Kymera Therapeutics
atopic dermatitis
Dupixent
JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US
Fierce Pharma
Tue, 01/14/25 - 06:21 pm
JPMHC 2025
Pharma CEOs
Sanofi
Paul Hudson
GSK
Emma Walmsley
vaccines
Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex
Fierce Pharma
Thu, 01/9/25 - 11:55 am
JNJ
Darzalex
Sanofi
Sarclisa
Multiple Myeloma
LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push
Fierce Biotech
Wed, 01/8/25 - 11:19 am
LB Pharma
schizophrenia
clinical trials
Sanofi
LB-102
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
I-Mab pauses Sanofi-partnered prospect to make play for busy CLDN18.2 space
Fierce Biotech
Mon, 01/6/25 - 10:57 am
I-Mab
Sanofi
CLDN18.2
solid tumors
Drugmakers plan price hikes for 250+ medications in 2025
Beckers Hospital Review
Wed, 01/1/25 - 10:31 pm
drug pricing
Pfizer
Sanofi
Bristol Myers Squibb
Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
Fierce Biotech
Fri, 12/20/24 - 11:26 am
Cytokinetics
Sanofi
China
aficamten
heart disease
Corxel Pharmaceuticals
FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates
Beckers Hospital Review
Tue, 12/17/24 - 12:09 pm
Sanofi
Novavax
COVID-19
vaccines
FDA
fast track
MRNA
Flu
Sanofi, Teva say study results show gut disease drug could be ‘best in class’
BioPharma Dive
Tue, 12/17/24 - 11:59 am
Sanofi
Teva Pharmaceutical
IBD
Merck
Roche
duvakitug
FDA Grants Breakthrough Therapy Designation to Sanofi’s Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis
Pharm Exec
Mon, 12/16/24 - 11:35 am
Sanofi
tolebrutinib
MS
non-relapsing secondary progressive MS
FDA
Sanofi announces its biggest China investment deal amid China-EU trade tensions
MSN/Reuters
Mon, 12/2/24 - 10:51 am
Sanofi
China
insulin
drug manufacturing
Sanofi adds new $600M manufacturing plant
Beckers Hospital Review
Sun, 12/1/24 - 11:50 am
Sanofi
drug manufacturing
Singapore
Sanofi plans to change hospital drug-discount program
Yahoo/Reuters
Sun, 11/24/24 - 06:01 pm
Sanofi
hospitals
340B
drug discounts
Sanofi lays out €40M to beef up transplant, diabetes drug production in France
Fierce Pharma
Mon, 11/18/24 - 06:37 pm
Sanofi
diabetes
type 1 diabetes
France
drug manufacturing
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Benzinga
Fri, 11/15/24 - 11:15 am
Regeneron
Sanofi
Dupixent
FDA
chronic spontaneous urticaria
Sanofi wins appeal in spat with NICE over Sarclisa
Pharmaphorum
Wed, 11/13/24 - 10:53 am
Sanofi
NHS
NICE
relapsed or refractory multiple myeloma
Sarclisa
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
PR Newswire
Tue, 11/12/24 - 09:55 am
Formation Bio
OpenAI
Sanofi
Muse
artificial intelligent
clinical trials
clinical trial recruitment

Pages